Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe completed RUXCOVID clinical trial record is displayed, with details on the study design, eligibility, outcomes, locations, results, and documents, instead of a 403 error screen.SummaryDifference84%

- Check15 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2; the study page still shows a 403 error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide NIH notice announces a terminology change from “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page now loads a 403 Forbidden error, replacing the study record content. Access to trial details, documents, and related information is no longer available on the page.SummaryDifference19%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.